
USFDA APPLICATION NUMBER - 209949 / DOSAGE - POWDER;INTRAVENOUS - 350MG/VIAL
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| DAPTOMYCIN(UNII: NWQ5N31VKK) (DAPTOMYCIN - UNII:NWQ5N31VKK) | DAPTOMYCIN | 350mg in 7 |
Inactive Ingredients
| Ingredient Name | Camber Pharmaceuticals, Inc. | Fresenius Kabi USA, LLC | NorthStar RxLLC | Xellia Pharmaceuticals USA LLC |
|---|---|---|---|---|
| SODIUM HYDROXIDE(55X04QC32I) |